Skip to main content

Biopharma Startups

Updated November 2026

Companies in the biopharma sector developing innovative solutions and technologies.

Explore 915 recently funded biopharma companies with verified founder contact information and fundraising data.

Total Companies
915
Total Funding
$638.1M
Avg Funding
$25.5M
Global Reach
8
countries

Top Cities for Biopharma

London
Cambridge
San Francisco
Paris
San Leandro
Austin

Recently Funded Companies

Export
London, United Kingdom

Consone AI a disruptive technology platform targeting decisions that are made in the drug development process.

$256K raised
Mar 2024

Founder Contacts

41,000+ verified contacts

Cambridge, United Kingdom

Transforming chronic wound care with breakthrough enzymatic technology

$518K raised
Mar 2024

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Junction Bioscience is a pharmaceutical firm that is developing an autonomous AI scientist to guide the discovery of breakthrough drugs.

$500K raised
Mar 2024

Founder Contacts

41,000+ verified contacts

Paris, France

Acticor Biotech is a biopharmaceutical company developing an innovative drug for the treatment in the acute phase of ischemic stroke.

$8.7M raised
Mar 2024

Founder Contacts

41,000+ verified contacts

San Leandro, United States

Tierra Biosciences is a synthetic biology company that offers an AI-driven platform with a vast range of custom proteins for research.

$11.4M raised
Mar 2024

Founder Contacts

41,000+ verified contacts

Austin, United States

Computational drug discovery leveraging generative AI to create therapeutics for neurodegenerative disorders.

$220K raised
Mar 2024

Founder Contacts

41,000+ verified contacts

Lisbon, Portugal

Lxbio Pharmaceuticals is a Pharmaceutical company that develops biopharmaceutical products for the treatment of diabetic foot infections.

$6.6M raised
Mar 2024

Founder Contacts

41,000+ verified contacts

Long Beach, United States

Bakhu Holdings produces, manufactures, and sells cannabis-related byproducts — sometimes referred to in the industry as cannabinoids.

$1.0M raised
Mar 2024

Founder Contacts

41,000+ verified contacts

Odense, Denmark

GlyProVac is pursuing the development of a glycoprotein based vaccine against Enterotoxigenic Escherichia coli (ETEC).

$467K raised
Feb 2024

Founder Contacts

41,000+ verified contacts

Niigata, Japan

UniBio is a biotech company that aims to produce useful proteins in plant cells via synthesis and the transient gene expression method.

$3.2M raised
Feb 2024

Founder Contacts

41,000+ verified contacts

Westlake Village, United States

Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing medical dermatology for unmet needs.

$150.0M raised
Feb 2024

Founder Contacts

41,000+ verified contacts

Vancouver, Canada

Metabolica Health is a biotechnology company in the development stage that identify and develop novel medicines for diabetes and obesity.

$741K raised
Feb 2024

Founder Contacts

41,000+ verified contacts

South Burlington, United States

Kria Botanicals is a wholesale producer of full-spectrum, organically grown CBD oil and terpenes.

$1.1M raised
Feb 2024

Founder Contacts

41,000+ verified contacts

Dundee, United Kingdom

PhaSER Biomedical discovery and develops human like predictions of drug efficacy.

$2.3M raised
Feb 2024

Founder Contacts

41,000+ verified contacts

Madrid, Spain

AptaTargets is a biopharmaceutical company focused in developing therapeutic

Feb 2024

Founder Contacts

41,000+ verified contacts

Syracuse, United States

BioNeex is a biopharma R&D open exchange platform and two-sided marketplace that directly connects biotech and biopharmaceutical.

$500K raised
Feb 2024

Founder Contacts

41,000+ verified contacts

The Woodlands, United States

Othram aims to revolutionize how forensic cases are solved, justice is served, and families are mended.

$6.6M raised
Feb 2024

Founder Contacts

41,000+ verified contacts

Carmel, United States

Sudo Biosciences is a biopharma company that designs and develops medicines that target the tyrosine kinase 2 (TYK2) pseudokinase domain.

$30.0M raised
Feb 2024

Founder Contacts

41,000+ verified contacts

Brooklyn, United States

Caladan Bio specializes in next-generation bioreactors, offering modular, affordable, and cutting-edge solutions.

$5.1M raised
Feb 2024

Founder Contacts

41,000+ verified contacts

Hayward, United States

Ocusphere Therapeutics Inc. is a biotech startup focused on gene therapy using non-viral vectors, targeting inherited retinal diseases.

$400K raised
Feb 2024

Founder Contacts

41,000+ verified contacts

Culver City, United States

NantBio offers treatments by developing molecularly targeted drugs, based on the molecular profile of the patient’s tumor.

$2.0M raised
Feb 2024

Founder Contacts

41,000+ verified contacts

London, United Kingdom

Astrophysics technology for precision therapy through accurate modelling of biology

Feb 2024

Founder Contacts

41,000+ verified contacts

London, United Kingdom

Autolus is a biopharmaceutical company focused on T-cell programming and manufacturing technology.

$350.0M raised
Feb 2024

Founder Contacts

41,000+ verified contacts

American Fork, United States

Eris Biotech is a biotech company that developing hypoxia-activated prodrugs (HAPs) for the treatment of solid tumors.

$500K raised
Feb 2024

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Attralus is a biopharmaceutical company focusing on creating transformative medicines to improve the lives of patients.

$56.0M raised
Feb 2024

Founder Contacts

41,000+ verified contacts

Showing 601 to 625 of 915 companies

About the Biopharma Startup Ecosystem

The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biopharma

Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biopharma Funding Breakdown

Here is how funding is distributed among the 915 biopharma companies tracked in the VCBacked database.

Average Funding
$25.5M
Total Funding Tracked
$638.1M
Countries Represented
8

Distribution by Funding Stage

Other25 companies

Top Cities for Biopharma

1.London
3 companies$350.3M
2.San Francisco
2 companies$56.5M
3.Cambridge
1 companies$518K
4.Paris
1 companies$8.7M
5.San Leandro
1 companies$11.4M

Related Industries

Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biopharma Startups?

Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked